These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23676787)

  • 1. Hepatitis B DNA vaccine-polycation nano-complexes enhancing immune response by percutaneous administration with microneedle.
    Yin D; Liang W; Xing S; Gao Z; Zhang W; Guo Z; Gao S
    Biol Pharm Bull; 2013; 36(8):1283-91. PubMed ID: 23676787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles.
    Seok H; Noh JY; Lee DY; Kim SJ; Song CS; Kim YC
    J Control Release; 2017 Nov; 265():66-74. PubMed ID: 28434892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
    Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
    Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Molecular Weight Polyethylenimine Modified with Pluronic 123 and RGD- or Chimeric RGD-NLS Peptide: Characteristics and Transfection Efficacy of Their Complexes with Plasmid DNA.
    Hu J; Zhao W; Liu K; Yu Q; Mao Y; Lu Z; Zhang Y; Zhu M
    Molecules; 2016 May; 21(5):. PubMed ID: 27213305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN.
    Qiu Y; Guo L; Zhang S; Xu B; Gao Y; Hu Y; Hou J; Bai B; Shen H; Mao P
    Drug Deliv; 2016 Sep; 23(7):2391-2398. PubMed ID: 25625495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superparamagnetic nanoparticles for effective delivery of malaria DNA vaccine.
    Al-Deen FN; Ho J; Selomulya C; Ma C; Coppel R
    Langmuir; 2011 Apr; 27(7):3703-12. PubMed ID: 21361304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the efficacy of malaria DNA vaccination with magnetic gene vectors.
    Nawwab Al-Deen F; Ma C; Xiang SD; Selomulya C; Plebanski M; Coppel RL
    J Control Release; 2013 May; 168(1):10-7. PubMed ID: 23500060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of magnetic polyplexes taken up efficiently by dendritic cell for enhanced DNA vaccine delivery.
    Nawwab Al-Deen FM; Selomulya C; Kong YY; Xiang SD; Ma C; Coppel RL; Plebanski M
    Gene Ther; 2014 Feb; 21(2):212-8. PubMed ID: 24352195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
    Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
    Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model.
    Cherif MS; Shuaibu MN; Kodama Y; Kurosaki T; Helegbe GK; Kikuchi M; Ichinose A; Yanagi T; Sasaki H; Yui K; Tien NH; Karbwang J; Hirayama K
    Vaccine; 2014 Apr; 32(17):1998-2006. PubMed ID: 24440206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles.
    Coulman SA; Barrow D; Anstey A; Gateley C; Morrissey A; Wilke N; Allender C; Brain K; Birchall JC
    Curr Drug Deliv; 2006 Jan; 3(1):65-75. PubMed ID: 16472095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system.
    Cole G; Ali AA; McCrudden CM; McBride JW; McCaffrey J; Robson T; Kett VL; Dunne NJ; Donnelly RF; McCarthy HO
    Eur J Pharm Biopharm; 2018 Jun; 127():288-297. PubMed ID: 29510205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles.
    Sahu KK; Pandey RS
    Int Immunopharmacol; 2016 Oct; 39():343-352. PubMed ID: 27526270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal delivery of plasmids expressing bovine herpesvirus 1 gB/gC/gD proteins by polyethyleneimine magnetic beads activates long-term immune responses in mice.
    Liu XB; Yu GW; Gao XY; Huang JL; Qin LT; Ni HB; Lyu C
    Virol J; 2021 Mar; 18(1):60. PubMed ID: 33743745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of HPV16E7 DNA vaccine transdermal delivery with microneedle array].
    Gao H; Pan JC; Chen B; Xue ZF; Li HD
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):663-6. PubMed ID: 19175177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy and hepatitis B virus clearance in mice enhanced by cell-mediated immunity with novel prime-boost regimens.
    Chuai X; Chen P; Chen H; Wang W; Deng Y; Ruan L; Li W; Tan W
    J Viral Hepat; 2017 Apr; 24(4):337-345. PubMed ID: 27885748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
    Jain S; Singh P; Mishra V; Vyas SP
    Immunol Lett; 2005 Oct; 101(1):41-9. PubMed ID: 15869802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.